Cornell team identifies first documented feline Marfan cases

A new Cornell-led case report may change how veterinarians think about a rare cluster of feline findings. Researchers at Cornell University College of Veterinary Medicine and the Baker Institute of Animal Health have published the first reported molecular characterization of Marfan syndrome in domestic cats, describing two sibling cats with classic connective-tissue features tied to a variant in FBN1. The study appeared in Scientific Reports on September 19, 2026, and Cornell announced the finding on September 22. (nature.com)

Marfan syndrome is well recognized in human medicine as a connective-tissue disorder caused by pathogenic variants in FBN1, with major manifestations in the cardiovascular, ocular, and skeletal systems. The new report matters partly because spontaneous animal models are rarely documented. According to the paper, this is the first phenotypic and molecular characterization of Marfan syndrome in domestic cats, extending a disease framework familiar in people into feline medicine. (nature.com)

The index cases were random-bred littermates, Gary and Shaggy. As kittens, Cornell said, they showed unusually long limbs, and later workups identified bilateral lens luxation and aortic root dilation, findings the authors describe as cardinal features of Marfan syndrome. Histopathology of the ascending aorta from one affected cat showed disrupted and fractured elastic fiber tendrils, changes the paper says are consistent with impaired fibrillin-1 function and medial degeneration seen in human Marfan syndrome. (nature.com)

Genetically, whole-genome sequencing identified a homozygous splice-region variant in FBN1 — reported as XM_023255387.2:c.2678-3C>A — that the authors said was absent from a cohort of more than 1,000 cats. Follow-up Oxford Nanopore cDNA sequencing found exon 22 skipping in 73% of transcripts. Even though both cats carried two altered copies, the authors concluded they were functionally heterozygous because the splice defect was incomplete, leaving low levels of normal transcript. Cornell’s news release emphasized that this residual function likely explains the cats’ survival into adulthood. (nature.com)

Direct outside reaction to the report appears limited so far, which isn’t unusual for a newly published, highly specific feline genetics paper. Still, the case intersects with two referral realities veterinarians already know well: lens luxation in cats often warrants specialist ophthalmology input, and aortic disease can be easy to miss without targeted imaging. Cornell’s specialty and genetics services already position inherited disease workups as part of referral care, which gives this finding a practical pathway into case recognition even before any formal test is broadly commercialized. (cuvs.org)

Why it matters: Clinically, this report gives veterinarians a new unifying explanation for a rare but important pattern of signs. In cats with lens instability or luxation, atypical body conformation, or unexplained aortic root enlargement, Marfan syndrome is now a documented consideration rather than a purely theoretical one. That could shape referral decisions in ophthalmology, cardiology, and medical genetics, and it may prompt more deliberate family-history discussions with pet parents when littermates are affected. The paper also reinforces a broader point for feline practice: genomics is increasingly turning unusual one-off cases into definable inherited syndromes with implications for diagnosis, screening, and breeding advice. (nature.com)

There are still important limits. This is a report centered on two siblings, not a prevalence study, and no broad feline screening recommendation has been issued. The inheritance pattern also appears more complex than the classic human teaching, since Marfan syndrome is usually autosomal dominant in people, while these cats carried a homozygous hypomorphic variant with partial residual function. That means veterinarians should see this as an early signal for recognition and case finding, not as a settled screening paradigm. (nature.com)

What to watch: The next steps are likely additional case reports, broader screening of feline DNA databases for rare FBN1 variants, and possible development of targeted testing through academic or specialty genetics programs if more clinically similar cats are identified. (nature.com)